ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2017
[Circular RNA CircHIPK3 Promotes NCI-H1299 and NCI-H2170 Cell Proliferation through miR-379 and its Target IGF1].
Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 43 citations in OpenAlex.
- [Research Progress of Circular RNA CircHIPK3 in Non-small Cell Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2024Review
- The emerging roles of circHECTD1 in human diseases and the specific underlying regulatory mechanisms.PeerJ · 2024Review
- Circular RNAs as biomarkers for lung cancer.Non-coding RNA research · 2023Review
- Circular RNAs: New layer of complexity evading breast cancer heterogeneity.Non-coding RNA research · 2023Article
- circRNA LDLRAD3 Enhances the Malignant Behaviors of NSCLC Cells via the miR-20a-5p-SLC7A5 Axis Activating the mTORC1 Signaling Pathway.Journal of healthcare engineering · 2022Article
- Understanding the Dual Roles of CircHIPK3 in Tumorigenesis and Tumor Progression.Journal of Cancer · 2022Review
- Blocking hsa_circ_0074027 suppressed non-small cell lung cancer chemoresistance via the miR-379-5p/IGF1 axis.Bioengineered · 2021Article
- Circular RNA circHIPK3 modulates prostate cancer progression via targeting miR-448/MTDH signaling.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021Article
- CircRNAs: Insights into Gastric Cancer.Gastrointestinal tumors · 2021Review
- Biogenesis, cellular effects, and biomarker value of circHIPK3.Cancer cell international · 2021Review
- iCDA-CMG: identifying circRNA-disease associations by federating multi-similarity fusion and collective matrix completion.Molecular genetics and genomics : MGG · 2021Article
- Advancement and properties of circular RNAs in prostate cancer: An emerging and compelling frontier for discovering.International journal of biological sciences · 2021Review
- CircHIPK3: Key Player in Pathophysiology and Potential Diagnostic and Therapeutic Tool.Frontiers in medicine · 2021Review
- Integrated analysis of circRNA-miRNA-mRNA network reveals potential prognostic biomarkers for radiotherapies with X-rays and carbon ions in non-small cell lung cancer.Annals of translational medicine · 2020Article
- Comprehensive profiling of circRNAs and the tumor suppressor function of circHIPK3 in clear cell renal carcinoma.Journal of molecular histology · 2020Article
- Circular RNA in Lung Cancer Research: Biogenesis, Functions, and Roles.International journal of biological sciences · 2020Review
- circRNA-miRNA-mRNA regulatory network in human lung cancer: an update.Cancer cell international · 2020Review
- Circular RNA HIPK3: A Key Circular RNA in a Variety of Human Cancers.Frontiers in oncology · 2020Review
- Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role.Critical reviews in oncology/hematology · 2020Review
- NCPCDA: network consistency projection for circRNA-disease association prediction.RSC advances · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIt has been proven that the circular RNA, possessing a stable covalently closed continuous loop, is a type of RNA molecule which is expressed widespread in mammals. The circular RNA circHIPK3 is abundantly expressed in hepatocellular carcinoma (HCC) and promotes tumourgenesis. However, a role for circHIPK3 has not been systematically examined in non-small cell lung cancer (NSCLC). In this study, we investigated whether circHIPK3 has an effect on cell proliferation in the NSCLC cell lines NCI-H1299 and NCI-H2170 and the underlying molecular mechanisms.
methodsThe expression of circHIPK3 was measured by real-time PCR in NSCLC cell lines. Nuclear mass separation experiment was used to detect the location of circHIPK3 in cells. The gain and loss function experiments were used to examine the proliferation of NCI-H1299 and NCI-H2170 cells by Cell Counting Kit-8 (CCK-8) and the colony formation assays. Then, circHIPK3 was cloned into the downstream of the luciferase reporter gene which activity was detected to verify whether miR-379 could bind with circHIPK3 or IGF1 mRNA. The protein level of IGF1 was detected by Western blot and ELISA in circHIPK3 overexpressed/knock-down NCI-H1299 and NCI-H2170 cells.
resultsCircHIPK3 was generally expressed in six kinds of NSCLC cells lines we detected, and the expression level was highest in H2170 and lowest in H1299. Overexpression of circHIPK3 obviously promoted NCI-H1299 cell proliferation and knock-down of circHIPK3 inhibited NCI-H2170 cell proliferation. In the luciferase assay, miR-379 was observed to sequester circHIPK3 and IGF1 mRNA with potential binding sites. Furthermore, we found that the overexpression of circHIPK3 could increase the expression levels of IGF1 and knock-down reduced it. Moreover, up-regulation of miR-379 rescued the phenotype induced by overexpression of circHIPK3.
conclusionsCircHIPK3 could promote cell proliferation by a circHIPK3/miR-379 pathway in NCI-H1299 and NCI-H2170 cells and might be a potential tumor biomarker for NSCLC. .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.